Reaction
Ileocaecal Resection reporting signals
As of the last recalculation, Ileocaecal Resection appears in 328 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB-FKJP (PRR 196.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab-Fkjp | 100 | 196.6 | 197.1 |
| Adalimumab-Aaty | 100 | 192.4 | 192.9 |
| Adalimumab-Adaz | 101 | 175.0 | 175.4 |
| Ustekinumab | 121 | 118.3 | 118.4 |
| Vedolizumab | 106 | 114.9 | 115.0 |
| Azathioprine | 93 | 93.1 | 93.2 |
| Infliximab | 139 | 69.4 | 69.4 |
| Infliximab-Dyyb | 29 | 69.0 | 69.0 |
| Mercaptopurine | 17 | 65.6 | 65.6 |
| Risankizumab-Rzaa | 50 | 45.6 | 45.6 |
| Upadacitinib | 48 | 43.6 | 43.6 |